drugset

drugset / Trial / NCT00478192

Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

NCT00478192 ↗

Phase 3 Completed 50 enrolled Cumberland Pharmaceuticals

RandomizedParallel-groupDouble-blindTreatment

Summary

The study is designed to assess the efficacy and safety of multiple infusions of conivaptan in subjects with euvolemic or hypervolemic hyponatremia

Timeline

Start: 2007-04
Primary completion: 2008-08
Completion: 2008-08

Publications

Background Koren MJ, Hamad A, Klasen S, Abeyratne A, McNutt BE, Kalra S. Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia. Am J Health Syst Pharm. 2011 May 1;68(9):818-27. doi: 10.2146/ajhp100260.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Conivaptan	Small molecule	20 mg	Intravenous

Indications

No indication recorded.